The purpose of the Planning and Evaluation Core (P&E Core) is to monitor the progress toward the implementation of goals and objectives of the Partnership. Planning and evaluation are the ultimate responsibilities of the Pis, and Drs.
J aim e Matta (PSM) and W. Jack Pledger (MCC) will lead this core and will be responsible for monitoring progress through ongoing evaluation processes, maximizing resources, identifying novel directions forthe Partnership, and reporting progress to institutional leaders and the NCI. The P&E Core includes the Internal Advisory Committee (JAC, P&E Table 1) and the Program Steering Committee (PSC, P&E Table 4). The lAC is responsible for internal planning and evaluation (P&E Core section 1) and new project selection (P&E Core section 2). The PSC provides external review and evaluation (P&E Core section 3). The decisions made by this core will be guided by data systematically accumulated and organized by the Evaluation Process Subcommittee (EPS) (membership below). This subcommittee is a unique strength of this core as it is led by an evaluation and process expert. Dr. Susan McMillan. Dr. McMillan is the Thompson Professor of Oncology Nursing at the University of South Florida, has training in evaluation and measurement, and has served as an evaluation consultant for several federal grants over the past decades. She is external to both PSM and MCC and as such will be able to objectively direct this subcommittee to produce formal systematic evaluations.

Agency
National Institute of Health (NIH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA163068-03
Application #
8728622
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
2014
Total Cost
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
Chen, Lu; Muñoz-Antonia, Teresita; Cress, W Douglas (2014) Trim28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines. PLoS One 9:e101040